Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 10.56 as of 2026-10-06T17:08:37.414Z.
Consensus retrieved: 2026-10-06T15:58:48.641Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:08:37.414Z.
Quote observation: 2026-10-06T17:05:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fa7775f0f235061f0bf2dad13cf3194ccfec9c689cebf54fc1cd2177b84bcbea
Forward PE Ratio (10.56) = Dated Quote Price ($47.29) / Consensus Forward EPS ($4.48)
FORWARD PE RATIO
10.56
SECTOR MEDIAN · FINANCIAL SERVICES
11.14
median of 363 covered companies
CURRENT VS SECTOR MEDIAN
-5.21%
vs the sector median at left
Root, Inc.
Market Cap
$663.01M
Forward PE Ratio
10.56
Market Cap
$648.78M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Root, Inc. (ROOT) | $663.01M | 10.56 |
| Gladstone Investment Corporation (GAINI)vs › | $670.37M | 25.32 |
| ACNB Corporation (ACNB)vs › | $652.65M | 11.29 |
| Donegal Group Inc. (DGICA)vs › | $673.47M | 10.15 |
| Carter Bankshares, Inc. (CARE)vs › | $673.95M | 5.03 |
| Chaince Digital Holdings Inc. (CD)vs › | $651.04M | N/A |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $650.99M | N/A |
| Capital Bancorp, Inc. (CBNK)vs › | $650.05M | 11.48 |
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)vs › | $648.78M | N/A |
| New Mountain Finance Corporation (NMFC)vs › | $646.53M | 6.29 |
Trailing P/E
14.0
reported TTM EPS
Forward P/E
10.6
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.48 implies +32.9% EPS growth vs the reported trailing $3.37.
At the dated quote price of $47.29, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $4.48 | $4.28 – $4.68 | 2 | 10.6x |
| 2027-12-31 | $2.42 | $2.31 – $2.53 | 2 | 19.5x |
| 2028-12-31 | $2.43 | $0.78 – $3.68 | 5 | 19.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
